Powder: -20°C for 3 years | In solvent: -80°C for 1 year
MeBIO is an agonist of aryl hydrocarbon receptor, with IC50 of 44 and 55 μM for GSK-3 and CDK1/CyclinB, respectively. MeBIO does not affect GSK-3β.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 33.00 | |
5 mg | In stock | $ 68.00 | |
10 mg | In stock | $ 119.00 | |
25 mg | In stock | $ 232.00 | |
50 mg | In stock | $ 373.00 | |
100 mg | In stock | $ 547.00 | |
500 mg | In stock | $ 1,190.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 78.00 |
Description | MeBIO is an agonist of aryl hydrocarbon receptor, with IC50 of 44 and 55 μM for GSK-3 and CDK1/CyclinB, respectively. MeBIO does not affect GSK-3β. |
Targets&IC50 | CDK5/p25:>100 μM, CDK1/CyclinB:55 μM, GSK-3:44 μM |
Molecular Weight | 370.2 |
Formula | C17H12BrN3O2 |
CAS No. | 667463-95-8 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 9 mg/mL (24.31 mM), Sonification is recommended
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
MeBIO 667463-95-8 Cell Cycle/Checkpoint Immunology/Inflammation PI3K/Akt/mTOR signaling Stem Cells GSK-3 Aryl Hydrocarbon Receptor CDK Glycogen synthase kinase-3 Aryl Hydrocarbon Receptor (AhR) Glycogen synthase kinase 3 Inhibitor inhibit AhR Agonist Cyclin dependent kinase inhibitor